UPDATE: Topeka Capital Markets Downgrades Polypore International on Near-term Headline Risk

In a report published on Thursday, Topeka Capital Markets analyst Chris Kapsch downgraded Polypore International (NYSE: PPO) from Buy to Hold and maintained a price target of $44.

In the report, Topeka Capital Markets stated, "While the modest improvement in EDV sales represents an inflection, the EDV adoption curve's slope remains muted, tempering our enthusiasm for PPO. Meanwhile, potentially imminent news re. Microporous could be a negative catalyst. Hence, we would now be on the sidelines at this juncture and valuation."

Polypore International closed on Wednesday at $44.33.